EP1292283A4 - A medicinal aerosol formulation - Google Patents

A medicinal aerosol formulation

Info

Publication number: EP1292283A4
Authority: EP; European Patent Office
Prior art keywords: aerosol formulation; medicinal aerosol; medicinal; formulation; aerosol
Prior art date: 2000-01-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP01901681A

Other languages

German (de)

French (fr)

Other versions

EP1292283A1 (en

Inventor

Akwete L Adjei

Yaping Zhu

John Z Sun

Simon Stefanos

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Aeropharm Technology LLC

Original Assignee

Aeropharm Technology LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-25

Filing date

2001-01-02

Publication date

2003-03-19

2000-10-30 Priority claimed from US09/702,195 external-priority patent/US6585957B1/en

2001-01-02 Application filed by Aeropharm Technology LLC filed Critical Aeropharm Technology LLC

2003-03-19 Publication of EP1292283A1 publication Critical patent/EP1292283A1/en

2003-03-19 Publication of EP1292283A4 publication Critical patent/EP1292283A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Otolaryngology (AREA)
Pulmonology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

EP01901681A 2000-01-25 2001-01-02 A medicinal aerosol formulation Withdrawn EP1292283A4 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US702195		1985-02-15
US17798700P	2000-01-25	2000-01-25
US177987P		2000-01-25
US09/702,195 US6585957B1 (en)	2000-01-25	2000-10-30	Medicinal aerosol formulation
PCT/US2001/000117 WO2001060420A1 (en)	2000-01-25	2001-01-02	A medicinal aerosol formulation

Publications (2)

Publication Number	Publication Date
EP1292283A1 EP1292283A1 (en)	2003-03-19
EP1292283A4 true EP1292283A4 (en)	2003-03-19

Family

ID=26873842

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP01901681A Withdrawn EP1292283A4 (en)	2000-01-25	2001-01-02	A medicinal aerosol formulation

Country Status (6)

Country	Link
EP (1)	EP1292283A4 (en)
JP (1)	JP2003524646A (en)
CN (1)	CN1440298A (en)
AU (1)	AU783120B2 (en)
CA (1)	CA2396796C (en)
MX (1)	MXPA02007187A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4707327B2 (en) *	2004-01-27	2011-06-22	旭化成ファーマ株式会社	Polypeptides adsorption inhibitors
ES2281222B1 (en) *	2004-09-24	2008-06-01	Grifols, S.A.	USE OF ALFA-1 ANTITRIPSIN FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF FIBROMIALGIA.
WO2008047364A2 (en) *	2006-10-18	2008-04-24	Periness Ltd.	Method and pharmacological composition for the diagnosis and treatment of male sub-fertility
SG11201607688YA (en) *	2014-04-03	2016-10-28	Csl Behring Ag	Nebulization of immunoglobulin
CN104162142A (en) *	2014-08-29	2014-11-26	宁波市微循环与莨菪类药研究所	Application of N-acetyl aspartoyl glutamic acid dipeptide preparation in treatment of heroin addiction

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0257956A2 (en) *	1986-08-19	1988-03-02	Genentech, Inc.	Device and dispersion for intrapulmonary delivery of polypeptide growth factors and cytokines
WO1995024183A1 (en) *	1994-03-07	1995-09-14	Inhale Therapeutic Systems	Methods and compositions for pulmonary delivery of insulin
WO2000016814A1 (en) *	1998-09-22	2000-03-30	Aeropharm Technology Incorporated	Medicinal aerosol formulation
WO2001049274A2 (en) *	1999-12-30	2001-07-12	Chiron Corporation	Methods for pulmonary delivery of interleukin-2

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1994021229A1 (en) *	1993-03-17	1994-09-29	Minnesota Mining And Manufacturing Company	Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid

2001
- 2001-01-02 EP EP01901681A patent/EP1292283A4/en not_active Withdrawn
- 2001-01-02 CN CN01807195A patent/CN1440298A/en active Pending
- 2001-01-02 MX MXPA02007187A patent/MXPA02007187A/en active IP Right Grant
- 2001-01-02 CA CA2396796A patent/CA2396796C/en not_active Expired - Fee Related
- 2001-01-02 AU AU27559/01A patent/AU783120B2/en not_active Ceased
- 2001-01-02 JP JP2001559515A patent/JP2003524646A/en active Pending

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0257956A2 (en) *	1986-08-19	1988-03-02	Genentech, Inc.	Device and dispersion for intrapulmonary delivery of polypeptide growth factors and cytokines
WO1995024183A1 (en) *	1994-03-07	1995-09-14	Inhale Therapeutic Systems	Methods and compositions for pulmonary delivery of insulin
WO2000016814A1 (en) *	1998-09-22	2000-03-30	Aeropharm Technology Incorporated	Medicinal aerosol formulation
WO2001049274A2 (en) *	1999-12-30	2001-07-12	Chiron Corporation	Methods for pulmonary delivery of interleukin-2

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KOEHLER D: "SYSTEMIC THERAPY WITH AEROSOLS", AEROSOLS IN MEDICINE. PRINCIPLES, DIAGNOSIS AND THERAPY, 1993, pages 303 - 319, XP002942706 *
See also references of WO0160420A1 *

Also Published As

Publication number	Publication date
JP2003524646A (en)	2003-08-19
AU783120B2 (en)	2005-09-29
CA2396796A1 (en)	2001-08-23
AU2755901A (en)	2001-08-27
EP1292283A1 (en)	2003-03-19
CA2396796C (en)	2011-06-21
CN1440298A (en)	2003-09-03
MXPA02007187A (en)	2002-12-09

Legal Events

Date	Code	Title	Description
2003-01-31	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2003-03-19	17P	Request for examination filed	Effective date: 20020812
2003-03-19	A4	Supplementary search report drawn up and despatched	Effective date: 20030122
2003-03-19	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
2003-03-19	AX	Request for extension of the european patent	Extension state: AL LT LV MK RO SI
2006-12-27	17Q	First examination report despatched	Effective date: 20061128
2012-12-21	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2013-01-23	18D	Application deemed to be withdrawn	Effective date: 20120801

Publication	Publication Date	Title
AU2753001A (en)	2001-11-12	A medicinal aerosol formulation
EP1296723A4 (en)	2006-06-21	A medicinal aerosol formulation
AU4519001A (en)	2002-01-30	A medicinal aerosol formulation
AU2001224716A1 (en)	2001-10-18	A medicinal aerosol formulation
AU2001226233A1 (en)	2001-11-12	A medicinal aerosol formulation
HUP0302311A3 (en)	2006-07-28	Medicinal aerosol formulations
EP1250127A4 (en)	2005-07-13	A method of administering a medicinal aerosol formulation
PL343491A1 (en)	2001-08-27	Pharmaceutical aerosol formulation
HK1045465A1 (en)	2002-11-29	A pharmaceutical formulation comprising megalatranand its prodrug
HUP0300405A3 (en)	2003-07-28	Aerosol inhaler
AU2001224718A1 (en)	2001-11-12	A medicinal aerosol formulation
AU2623401A (en)	2001-11-12	A medicinal aerosol formulation
AU2001259318A1 (en)	2001-11-12	A medicinal aerosol formulation
HUP0600143A2 (en)	2006-10-28	A stable pharmaceutical formulation comprising torsemide modification ii
GB9924992D0 (en)	1999-12-22	Pharmaceutical aerosol formulations
EP1292283A4 (en)	2003-03-19	A medicinal aerosol formulation
AU2001227531A1 (en)	2001-11-12	A medicinal aerosol formulation
AU2001247123A1 (en)	2002-02-05	A medicinal aerosol formulation
GB0014849D0 (en)	2000-08-09	Pharmaceutical aerosol formulation
GB0013400D0 (en)	2000-07-26	A formulation
GB0014851D0 (en)	2000-08-09	Novel pharmaceutical formulation
GB0014883D0 (en)	2000-08-09	Novel pharmaceutical formulation
GB0014947D0 (en)	2000-08-09	Novel pharmaceutical formulation
GB0014892D0 (en)	2000-08-09	Novel pharmaceutical formulation
GB0014881D0 (en)	2000-08-09	Pharmaceutical aerosol formulation